Charles Morgan Kendrick JR - Mar 1, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & President, Commercial
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2024
Transactions value $
-$740,679
Form type
4
Date filed
3/5/2024, 04:27 PM
Previous filing
Nov 3, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$741K -1.48K -9.73% $499.11 13.8K Mar 1, 2024 Direct F1
transaction ELV Common Stock Award $0 +2.15K +15.65% $0.00 15.9K Mar 1, 2024 Direct F2
transaction ELV Common Stock Award $0 +2.35K +14.79% $0.00 18.3K Mar 1, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +8.31K $0.00 8.31K Mar 1, 2024 Common Stock 8.31K $499.11 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows:718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.
F3 Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4 The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.